ワシントンにおけるアルツハイマー病の臨床試験
ワシントン内の拠点で、アルツハイマー病に関する17件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/30更新 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
被験者募集中第2相
55歳以上 · 全性別 · 2026/09/29更新 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1644, Seattle
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/28更新 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- University of Washington, Seattle
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/25更新 · NCT00869817A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
被験者募集中第2相
55歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
被験者募集中第2相
55歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- EvergreenHealth Medical Center, Kirkland
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1644, Seattle
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011732Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Fred Hutchinson Cancer Center, Seattle
被験者募集中観察研究健康なボランティア歓迎参加者への支払いあり
18歳以上 · 全性別 · 2026/08/19更新 · NCT06922188Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Northwest Clinical Research Center, Bellevue
- Universal Research Group, Tacoma
被験者募集中第3相
55歳以上 · 全性別 · 2026/07/07更新 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Washington Medical Center, Seattle
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/06/26更新 · NCT07094516Late Onset Alzheimer's Disease
- University of Washington, Seattle
被験者募集中観察研究健康なボランティア歓迎
55歳以上 · 全性別 · 2026/05/18更新 · NCT05010603A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
被験者募集中
60歳以上 · 全性別 · 2025/07/20更新 · NCT06411561ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。